PTRH2 and esophageal squamous cell carcinoma: The oncogenic role of PTRH2 in ESCC may be partly explained by PTRH2’s activation of Bcl2 expression downstream of integrin ligation and PTRH2’s interaction with and activation of FAK3 and its ability to activate a FAK-paxillin pathway58.